Claritas Genomics HLH/MAS Region of Interest Test
Claritas Genomics has launched the Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS) Region of Interest test to its menu of exome-based molecular diagnostic testing. The test encompases 20 genes relevant to autosomal recessive or x-linked primary HLH and auto-inflammatory disease that can trigger MAS. It also identifies variants in exons and adjacent intronic sequences and detects deep intronic variants in UNC13D. The assay uses the company's dual-capture, dual sequencing platform method.